Determine the necessary mass, volume, or concentration for preparing a solution.
JPS014 TFA is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimeras ( PROTAC ). JPS014 TFA degrades class I histone deacetylase ( HDAC ). JPS014 TFA is potent HDAC1/2 degrader correlated with greater total differentially expressed genes and enhanced apoptosis in HCT116 cells.
No tested application protocols are provided for this item. As general guidance for small-molecule screening compounds (not item-specific):
For any validated, item-specific methods (WB, IHC, IF, FC, enzyme assays, etc.), refer to project documentation or request technical support.
Item-specific biological function: Not specified for this item; no target, pathway, or mechanism information is provided in the Product Data.
General context for small-molecule screening compounds (not item-specific):
Experimental recommendations (general):
No clinical or therapeutic claims are made; this product is provided strictly for research use only.
This product is not a buffering agent. However, as a TFA salt, it may modestly acidify aqueous solutions.
Item-specific buffer data: Not specified for this item; refer to CoA/Spec Sheet.
General practical guidance (not item-specific):
Compatibility notes (general):
This section provides general best practices only; no item-specific buffering parameters are available.
Because the structure-specific use pattern is unknown, solvent selection drives most environmental impact for small-molecule handling. The following comparison is general guidance for preparing solutions of TFA salts in a greener manner.
| Use case | Conventional choice | Greener alternative | Tradeoffs | |---|---|---|---| | Concentrated assay stocks | DMSO | Glycerol, PEG-400 (co-solvent), propylene carbonate | Higher viscosity; potential assay interference; sometimes lower solubility | | Workup/extraction | Dichloromethane, chloroform | Ethyl acetate, 2-MeTHF, CPME | Partitioning may differ; salts often remain in aqueous unless basified | | Recrystallization | Acetone/ACN | EtOAc/IPA/water systems | Solubility behavior is scaffold-dependent | | Mobile phase acid | TFA (0.1%) | Formic acid or acetic acid | Improved MS sensitivity; different chromatographic selectivity |
Note: Implement changes only after verifying compound stability, solubility, and assay compatibility.
No pharmacopeial status, excipient role, or formulation specifications are provided for this item. It is supplied strictly for research use only and is not intended for human or veterinary use.
General considerations for salt forms in development (not item-specific):
Formulation notes (general):
Refer to internal development SOPs and regulatory guidance for any use beyond discovery-stage research.
Item-specific physicochemical data are not provided in the Product Data.
Item-specific values:
General guidance for TFA salts (literature/general, not item-specific):
Practical note:
Item-specific quality data:
Interpreting salt form (general guidance):
Typical expectations for screening-library items (general):
Practical QA considerations:
For definitive grade, purity, and analytical specifications, refer to the lot-specific CoA/Spec Sheet.
Intended use (from Product Data): For research use only. No manufacturer application text is provided for this specific item.
General applications for small-molecule TFA salts (not item-specific):
Analytical considerations (general):
Practical workflow tips (general):
No item-specific reactivity or condition ranges are provided. The following general guidance applies to handling TFA salts when transitioning to synthetic operations (not item-specific):
Free base generation (general):
Salt exchange (general):
Analytical checkpoints:
Stability considerations:
These are literature-style general procedures. Optimize conditions for the confirmed structure of JPS014 before scale-up.
Safety information specific to this item is not provided in the Product Data. Handle in accordance with good laboratory practice and consult the product SDS for authoritative guidance.
Item-specific hazard data:
General precautions (good practice; not item-specific):
Storage & handling conditions (item-specific from Product Data):
First-aid overview (general):
Always defer to the SDS for definitive hazard communication.
This product is a small-molecule TFA salt; solvent strategy depends on the underlying scaffold. Item-specific solubility is not provided.
Item-specific solubility: Not specified for this item; refer to CoA/Spec Sheet.
General solvent guidance for TFA salts (literature/general):
Dielectric/polarity considerations (general):
Quick comparison (general):
Practical tips:
Item-specific storage/shipping (from Product Data):
Stability notes (general):
Reconstitution guidance (general, not item-specific):
Freeze–thaw management (general):
Always refer to the lot-specific CoA/SDS for definitive stability, reconstitution concentration limits, and storage durations.
Brief overview: This listing is for a small-molecule screening compound denoted “JPS014 TFA,” indicating a trifluoroacetate (TFA) salt form. Item-specific structural identifiers are not provided in the Product Data.
Item-specific identifiers (from Product Data):
Interpreting the name (general chemistry knowledge):
Structural features (general expectations for TFA salts):
2D structure description (item-specific):
Item-specific functional groups are not disclosed. Nevertheless, the TFA salt designation offers general synthetic implications:
General transformations enabled by TFA salts of amines (not item-specific):
Analytical leverage (general):
Cautions:
Because the core scaffold of “JPS014” is unspecified, devise reaction plans only after confirming structure and functional groups from the CoA/structure file.
Not applicable. This product is a small-molecule compound from a screening library; no antibody/biologic target, clone, or isotype information is relevant or provided. Item-specific target data are not specified for this item; refer to CoA/Spec Sheet if available.